K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar

BACKGROUND: Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Myanmar-Thailand border raise concerns over resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Win, Aye A., Imwong, Mallika, Kyaw, Myat P., Woodrow, Charles J., Chotivanich, Kesinee, Hanboonkunupakarn, Borimas, Pukrittayakamee, Sasithon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765153/
https://www.ncbi.nlm.nih.gov/pubmed/26911145
http://dx.doi.org/10.1186/s12936-016-1147-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765153/
https://www.ncbi.nlm.nih.gov/pubmed/26911145
http://dx.doi.org/10.1186/s12936-016-1147-3

Ejemplares similares